Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,408 | 1,021 | 1,658 | 1,691 | 597 |
| Marketable Securities | 148 | 148 | 148 | 0 | 0 |
| Receivables | 162 | 1,988 | 558 | 1,155 | 1,034 |
| Inventories | 650 | 650 | 486 | N/A | N/A |
| Other current assets | 373 | 353 | 355 | 0 | 0 |
| TOTAL | $7,741 | $4,159 | $3,205 | $3,226 | $2,024 |
| Non-Current Assets | |||||
| PPE Net | 5,675 | 5,969 | 6,237 | 951 | 953 |
| Investments And Advances | 794 | 795 | 799 | 6,016 | 6,013 |
| Intangibles | 1,521 | 133 | 128 | 323 | 310 |
| Other Non-Current Assets | 819 | 460 | 484 | 821 | 692 |
| TOTAL | $8,809 | $7,357 | $7,648 | $8,110 | $7,968 |
| Total Assets | $16,550 | $11,516 | $10,853 | $11,336 | $9,992 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 45 | 1,473 | 258 | 675 | 613 |
| Accrued Expenses | N/A | N/A | 288 | 175 | 198 |
| Other current liabilities | 659 | 426 | N/A | 474 | 410 |
| TOTAL | $2,504 | $3,699 | $2,346 | $1,324 | $1,220 |
| Non-Current Liabilities | |||||
| Long Term Debt | 225 | 226 | 427 | 2,537 | 2,551 |
| Other Non-Current Liabilities | 14 | 14 | 15 | 0 | 0 |
| TOTAL | $239 | $241 | $442 | $2,537 | $2,551 |
| Total Liabilities | $2,743 | $3,939 | $2,788 | $3,861 | $3,771 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,348 | 31,038 | 31,028 | 30,282 | 28,065 |
| Common Shares | 71,670 | 64,248 | 63,917 | 3 | 3 |
| Retained earnings | -55,166 | -54,308 | -53,795 | -53,219 | -52,688 |
| Other shareholders' equity | -2,697 | -2,363 | -2,057 | -2,047 | -2,068 |
| TOTAL | $13,807 | $7,577 | $8,065 | $7,475 | $6,221 |
| Total Liabilities And Equity | $16,550 | $11,516 | $10,853 | $11,336 | $9,992 |